Skip to main content
logo
CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.87
-1.09 (-9.11%)
At close: Mar 6, 2026

HKG:2171 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
125.6639.43--25.81
Revenue Growth (YoY)
218.74%----
Cost of Revenue
45.7124.68---
Gross Profit
79.9514.75--25.81
Selling, General & Admin
69.83162.84133.31136.61126.52
Research & Development
245.36463.74660.04679.49501.03
Other Operating Expenses
-131.03139.91-8.3-10.45-14.34
Operating Expenses
184.16766.49785.05805.65613.21
Operating Income
-104.21-751.75-785.05-805.65-587.4
Interest Expense
-6.9-5.71-4.66-15.52-10.87
Interest & Investment Income
-41.9272.7927.579.61
Currency Exchange Gain (Loss)
--82.24-30.47-97.357.45
Other Non Operating Income (Expenses)
8.2----4,156
Pretax Income
-102.91-797.79-747.39-890.95-4,737
Income Tax Expense
-0.350.411.37.65
Earnings From Continuing Operations
-102.91-798.13-747.79-892.25-4,744
Minority Interest in Earnings
5.05----
Net Income
-97.86-798.13-747.79-892.25-4,744
Net Income to Common
-97.86-798.13-747.79-892.25-4,744
Shares Outstanding (Basic)
544553556552387
Shares Outstanding (Diluted)
544553556552387
Shares Change (YoY)
-1.67%-0.58%0.82%42.60%95.23%
EPS (Basic)
-0.18-1.44-1.34-1.62-12.26
EPS (Diluted)
-0.18-1.44-1.34-1.62-12.26
Free Cash Flow
-236.9-427.69-463.77-778.45-688.16
Free Cash Flow Per Share
-0.44-0.77-0.83-1.41-1.78
Gross Margin
63.62%37.41%--100.00%
Operating Margin
-82.93%-1906.78%---2275.59%
Profit Margin
-77.88%-2024.43%---18379.97%
Free Cash Flow Margin
-188.52%-1084.81%---2665.95%
EBITDA
-39.08-686.61-717.64-748.73-552.49
EBITDA Margin
-31.10%----
D&A For EBITDA
65.1465.1467.4156.9234.91
EBIT
-104.21-751.75-785.05-805.65-587.4
EBIT Margin
-82.93%----
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.